{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:09:17Z","timestamp":1786540157384,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11899-021-00634-4","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T10:02:52Z","timestamp":1621418572000},"page":"140-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Enteropathy-Associated T cell Lymphoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Zakiah","family":"Al Somali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"El Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"634_CR1","unstructured":"Wd T, et al. World Health Organization Classification of Tumours This book and all other volumes of the series can be purchased: from all countries. World Health Organization; 2017."},{"key":"634_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","volume":"118","author":"J Delabie","year":"2011","unstructured":"Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011;118:148\u201355.","journal-title":"Blood"},{"key":"634_CR3","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"634_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","volume":"45","author":"G Malamut","year":"2013","unstructured":"Malamut G, Chandesris O, Verkarre V, Meresse B, Callens C, Macintyre E, et al. Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis. 2013;45:377\u201384.","journal-title":"Dig Liver Dis"},{"key":"634_CR5","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","volume":"115","author":"M Sieniawski","year":"2010","unstructured":"Sieniawski M, Angamuthu N, Boyd K, Chasty R, Davies J, Forsyth P, et al. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood. 2010;115:3664\u201370.","journal-title":"Blood"},{"key":"634_CR6","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1080\/00365520802240222","volume":"43","author":"WHM Verbeek","year":"2008","unstructured":"Verbeek WHM, van de Water JMW, al-Toma A, Oudejans JJ, Mulder CJJ, Coup\u00e9 VMH. Incidence of enteropathy - associated T-cell lymphoma: A nation-wide study of a population-based registry in The Netherlands. Scand J Gastroenterol. 2008;43:1322\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"634_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","volume":"18","author":"J Gale","year":"2000","unstructured":"Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single Center. J Clin Oncol. 2000;18:795\u2013803.","journal-title":"J Clin Oncol"},{"key":"634_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0140-6736(01)05554-4","volume":"358","author":"G Corrao","year":"2001","unstructured":"Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001;358:356\u201361.","journal-title":"Lancet"},{"issue":"5","key":"634_CR9","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1053\/gast.2002.36585","volume":"123","author":"J Askling","year":"2002","unstructured":"Askling J, Linet M, Gridley G, Halstensen TS, Ekstr\u00f6m K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123(5):1428\u201335.","journal-title":"Gastroenterology"},{"key":"634_CR10","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1023\/A:1026655609906","volume":"44","author":"M Cottone","year":"1999","unstructured":"Cottone M, Termini A, Oliva L, Magliocco A, Marrone C, Orlando A, et al. Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci. 1999;44:2538\u201341.","journal-title":"Dig Dis Sci"},{"key":"634_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/j.gastro.2008.09.031","volume":"136","author":"Y Gao","year":"2009","unstructured":"Gao Y, Kristinsson SY, Goldin LR, Bj\u00f6rkholm M, Caporaso NE, Landgren O. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology. 2009;136:91\u20138.","journal-title":"Gastroenterology"},{"key":"634_CR12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/gut.2006.114512","volume":"56","author":"A Al-Toma","year":"2007","unstructured":"Al-Toma A, Verbeek WHM, Hadithi M, von Blomberg BME, Mulder CJJ. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56:1373\u20138.","journal-title":"Gut"},{"key":"634_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.dld.2011.07.012","volume":"43","author":"O Ol\u00e9n","year":"2011","unstructured":"Ol\u00e9n O, Askling J, Ludvigsson JF, Hildebrand H, Ekbom A, Smedby KE. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis. 2011;43:862\u20138.","journal-title":"Dig Liver Dis"},{"key":"634_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/gut.30.3.333","volume":"30","author":"GK Holmes","year":"1989","unstructured":"Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease--effect of a gluten free diet. Gut. 1989;30:333\u20138.","journal-title":"Gut"},{"key":"634_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/ajh.23992","volume":"90","author":"P Nijeboer","year":"2015","unstructured":"Nijeboer P, de Baaij LR, Visser O, Witte BI, Cillessen SAGM, Mulder CJ, et al. Treatment response in enteropathy associated T-cell lymphoma: survival in a large multicenter cohort. Am J Hematol. 2015;90:493\u20138.","journal-title":"Am J Hematol"},{"key":"634_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11894-020-0756-8","volume":"22","author":"IA Hujoel","year":"2020","unstructured":"Hujoel IA, Murray JA. Refractory celiac disease. Curr Gastroenterol Rep. 2020;22:18.","journal-title":"Curr Gastroenterol Rep"},{"key":"634_CR17","doi-asserted-by":"publisher","first-page":"e000026","DOI":"10.1136\/bmjgast-2014-000026","volume":"2","author":"RLJ van Wanrooij","year":"2015","unstructured":"van Wanrooij RLJ, et al. Novel variant of EATL evolving from mucosal \u03b3\u03b4-T-cells in a patient with type I RCD. BMJ Open Gastroenterol. 2015;2:e000026.","journal-title":"BMJ Open Gastroenterol"},{"key":"634_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/imr.12191","volume":"260","author":"V Abadie","year":"2014","unstructured":"Abadie V, Jabri B. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev. 2014;260:221\u201334.","journal-title":"Immunol Rev"},{"key":"634_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer S, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (80- ). 1999;285:727\u20139.","journal-title":"Science (80- )"},{"key":"634_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.285.5428.730","volume":"285","author":"J Wu","year":"1999","unstructured":"Wu J, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science (80- ). 1999;285:730\u20132.","journal-title":"Science (80- )"},{"key":"634_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11899-018-0459-5","volume":"13","author":"U Chander","year":"2018","unstructured":"Chander U, Leeman-Neill RJ, Bhagat G. Pathogenesis of enteropathy-associated T cell lymphoma. Curr Hematol Malig Rep. 2018;13:308\u201317.","journal-title":"Curr Hematol Malig Rep"},{"key":"634_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/gutjnl-2018-317371","volume":"68","author":"M Cheminant","year":"2019","unstructured":"Cheminant M, Bruneau J, Malamut G, Sibon D, Guegan N, van Gils T, et al. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study. Gut. 2019;68:1396\u2013405.","journal-title":"Gut"},{"key":"634_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","volume":"126","author":"WHM Verbeek","year":"2008","unstructured":"Verbeek WHM, Goerres MS, von Blomberg BME, Oudejans JJ, Scholten PET, Hadithi M, et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Clin Immunol. 2008;126:48\u201356.","journal-title":"Clin Immunol"},{"key":"634_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gut.52.2.205","volume":"52","author":"V Verkarre","year":"2003","unstructured":"Verkarre V, Asnafi V, Lecomte T, Patey Mariaud-de Serre N, Leborgne M, Grosdidier E, et al. Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut. 2003;52:205\u201311.","journal-title":"Gut"},{"key":"634_CR25","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1182\/blood-2014-04-566513","volume":"123","author":"J Pastr\u00e9","year":"2014","unstructured":"Pastr\u00e9 J, Juvin K, Malamut G, Derrieux C, Cellier C, Isra\u00ebl-Biet D. Phenotypically aberrant clonal T cells in the lungs of patients with type II refractory celiac disease. Blood. 2014;123:3674\u20135.","journal-title":"Blood"},{"key":"634_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","volume":"125","author":"J-J Mention","year":"2003","unstructured":"Mention J-J, Ben Ahmed M, B\u00e8gue B, Barbe U, Verkarre V, Asnafi V, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology. 2003;125:730\u201345.","journal-title":"Gastroenterology"},{"key":"634_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","volume":"136","author":"G Malamut","year":"2009","unstructured":"Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, Damotte D, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136:81\u201390.","journal-title":"Gastroenterology"},{"key":"634_CR28","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/01.LAB.0000090157.13040.58","volume":"83","author":"AK Baumg\u00e4rtner","year":"2003","unstructured":"Baumg\u00e4rtner AK, Zettl A, Chott A, Ott G, M\u00fcller-Hermelink HK, Starostik P. High frequency of genetic aberrations in enteropathy-type T-cell lymphoma. Lab Investig. 2003;83:1509\u201316.","journal-title":"Lab Investig"},{"key":"634_CR29","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","volume":"132","author":"RJ deLeeuw","year":"2007","unstructured":"deLeeuw RJ, et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology. 2007;132:1902\u201311.","journal-title":"Gastroenterology"},{"key":"634_CR30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","volume":"161","author":"A Zettl","year":"2002","unstructured":"Zettl A, Ott G, Makulik A, Katzenberger T, Starostik P, Eichler T, et al. Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol. 2002;161:1635\u201345.","journal-title":"Am J Pathol"},{"key":"634_CR31","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20160894","volume":"214","author":"AB Moffitt","year":"2017","unstructured":"Moffitt AB, Ondrejka SL, McKinney M, Rempel RE, Goodlad JR, Teh CH, et al. Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J Exp Med. 2017;214:1371\u201386.","journal-title":"J Exp Med"},{"key":"634_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/bmj.286.6358.16","volume":"286","author":"JN Leonard","year":"1983","unstructured":"Leonard JN, Tucker WF, Fry JS, Coulter CA, Boylston AW, McMinn RM, et al. Increased incidence of malignancy in dermatitis herpetiformis. Br Med J (Clin Res Ed). 1983;286:16\u20138.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"634_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.308.6920.13","volume":"308","author":"B Sigurgeirsson","year":"1994","unstructured":"Sigurgeirsson B, Agnarsson BA, Lindel\u00f6f B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ. 1994;308:13\u20135.","journal-title":"BMJ"},{"key":"634_CR34","first-page":"578","volume":"48","author":"F Branchi","year":"2016","unstructured":"Branchi F, et al. Enteroscopy and radiology for the management of celiac disease complications: time for a pragmatic roadmap. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2016;48:578\u201386.","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"634_CR35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.gie.2017.04.006","volume":"86","author":"L Elli","year":"2017","unstructured":"Elli L, et al. Use of enteroscopy for the detection of malignant and premalignant lesions of the small bowel in complicated celiac disease: a meta-analysis. Gastrointest Endosc. 2017;86:264\u2013273.e1.","journal-title":"Gastrointest Endosc"},{"key":"634_CR36","first-page":"1622","volume":"47","author":"M Hadithi","year":"2006","unstructured":"Hadithi M, Mallant M, Oudejans J, van Waesberghe J, Mulder CJ, Comans EF. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med. 2006;47:1622\u20137.","journal-title":"J Nucl Med"},{"key":"634_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/gut.52.3.347","volume":"52","author":"M Hoffmann","year":"2003","unstructured":"Hoffmann M, Vogelsang H, Kletter K, Zettinig G, Chott A, Raderer M. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut. 2003;52:347\u201351.","journal-title":"Gut"},{"key":"634_CR38","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1182\/blood-2011-10-385559","volume":"119","author":"A Di Sabatino","year":"2012","unstructured":"Di Sabatino A, Biagi F, Gobbi PG, Corazza GR. How I treat enteropathy-associated T-cell lymphoma. Blood. 2012;119:2458\u201368.","journal-title":"Blood"},{"key":"634_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","volume":"5","author":"A Rohatiner","year":"1994","unstructured":"Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol Off J Eur Soc Med Oncol. 1994;5:397\u2013400.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"634_CR40","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"634_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"MA Shipp","year":"1993","unstructured":"Shipp MA. International non-Hodgkin\u2019s lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329:987\u201394.","journal-title":"N Engl J Med"},{"key":"634_CR42","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1158\/1078-0432.CCR-14-2195","volume":"21","author":"LR de Baaij","year":"2015","unstructured":"de Baaij LR, Berkhof J, van de Water JMW, Sieniawski MK, Radersma M, Verbeek WHM, et al. A new and validated clinical prognostic model (EPI) for enteropathy-associated T-cell lymphoma. Clin Cancer Res an Off J Am Assoc Cancer Res. 2015;21:3013\u20139.","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"634_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000369542","volume":"33","author":"P Nijeboer","year":"2015","unstructured":"Nijeboer P, Malamut G, Mulder CJ, Cerf-Bensussan N, Sibon D, Bouma G, et al. Enteropathy-associated T-cell lymphoma: improving treatment strategies. Dig Dis. 2015;33:231\u20135.","journal-title":"Dig Dis"},{"key":"634_CR44","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.clnu.2015.04.014","volume":"35","author":"NJ Wierdsma","year":"2016","unstructured":"Wierdsma NJ, Nijeboer P, de van der Schueren MAE, Berkenpas M, van Bodegraven AA, Mulder CJJ. Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis. Clin Nutr. 2016;35:685\u201391.","journal-title":"Clin Nutr"},{"key":"634_CR45","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1182\/blood-2012-11-466839","volume":"121","author":"E Jantunen","year":"2013","unstructured":"Jantunen E, Boumendil A, Finel H, Luan JJ, Johnson P, Rambaldi A, et al. Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT. Blood. 2013;121:2529\u201332.","journal-title":"Blood"},{"key":"634_CR46","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F d\u2019Amore","year":"2012","unstructured":"d\u2019Amore F, et al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:3093\u20139.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"634_CR47","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1200\/JCO.2003.06.026","volume":"21","author":"S Daum","year":"2003","unstructured":"Daum S, Ullrich R, Heise W, Dederke B, Foss HD, Stein H, et al. Intestinal non-Hodgkin\u2019s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin\u2019s Lymphoma. J Clin Oncol. 2003;21:2740\u20136.","journal-title":"J Clin Oncol"},{"key":"634_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11899-011-0097-7","volume":"6","author":"MK Sieniawski","year":"2011","unstructured":"Sieniawski MK, Lennard AL. Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies. Curr Hematol Malig Rep. 2011;6:231\u201340.","journal-title":"Curr Hematol Malig Rep"},{"key":"634_CR49","doi-asserted-by":"publisher","first-page":"12403","DOI":"10.3748\/wjg.v21.i43.12403","volume":"21","author":"JMW van de Water","year":"2015","unstructured":"van de Water JMW, et al. Surgery in (pre)malignant celiac disease. World J Gastroenterol. 2015;21:12403\u20139.","journal-title":"World J Gastroenterol"},{"key":"634_CR50","first-page":"191","volume":"16","author":"BJ Novakovic","year":"2006","unstructured":"Novakovic BJ, Novakovic S, Frkovic-Grazio S. A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin\u2019s lymphomas. Oncol Rep. 2006;16:191\u20135.","journal-title":"Oncol Rep"},{"key":"634_CR51","doi-asserted-by":"publisher","unstructured":"W\u00f6hrer S, Chott A, Drach J, P\u00fcsp\u00f6k A, Hejna M, Hoffmann M, et al. Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. 2004:1680\u20133. https:\/\/doi.org\/10.1093\/annonc\/mdh427.","DOI":"10.1093\/annonc\/mdh427"},{"key":"634_CR52","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/bloodadvances.2017010819","volume":"1","author":"YA Kim","year":"2017","unstructured":"Kim YA, Byun JM, Park K, Bae GH, Lee D, Kim DS, et al. Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma. Blood Adv. 2017;1:2138\u201346.","journal-title":"Blood Adv"},{"key":"634_CR53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","volume":"393","author":"S Horwitz","year":"2019","unstructured":"Horwitz S, et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019;393:229\u201340.","journal-title":"Lancet"},{"key":"634_CR54","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00277-013-1880-4","volume":"92","author":"C Binder","year":"2013","unstructured":"Binder C, et al. CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial. Ann Hematol. 2013;92:1521\u20138.","journal-title":"Ann Hematol"},{"key":"634_CR55","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1182\/blood.V130.Suppl_1.821.821","volume":"130","author":"N Mehta-Shah","year":"2017","unstructured":"Mehta-Shah N, et al. Successful treatment of mature T-cell lymphoma with allogeneic stem cell transplantation: the largest multicenter retrospective analysis. Blood. 2017;130:4597.","journal-title":"Blood"},{"key":"634_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00004836-199509000-00012","volume":"21","author":"LJ Egan","year":"1995","unstructured":"Egan LJ, et al. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol. 1995;21:123\u20139.","journal-title":"J Clin Gastroenterol"},{"key":"634_CR57","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1080\/10428194.2017.1312379","volume":"58","author":"T Skamene","year":"2017","unstructured":"Skamene T, Crump M, Savage KJ, Reiman T, Kuruvilla J, Good D, et al. Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study(). Leuk Lymphoma. 2017;58:2319\u201327.","journal-title":"Leuk Lymphoma"},{"key":"634_CR58","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00277-015-2468-y","volume":"94","author":"B-B Park","year":"2015","unstructured":"Park B-B, Kim WS, Suh C, Shin DY, Kim JA, Kim HG, et al. Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial. Ann Hematol. 2015;94:1845\u201351.","journal-title":"Ann Hematol"},{"key":"634_CR59","doi-asserted-by":"crossref","unstructured":"Foster C, Kuruvilla J. Treatment approaches in relapsed or refractory peripheral T-cell lymphomas. F1000Research. 2020;9.","DOI":"10.12688\/f1000research.22257.1"},{"key":"634_CR60","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","volume":"31","author":"V Mak","year":"2013","unstructured":"Mak V, Hamm J, Chhanabhai M, Shenkier T, Klasa R, Sehn LH, et al. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31:1970\u20136.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"634_CR61","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/19420862.2017.1332553","volume":"9","author":"AP Vicari","year":"2017","unstructured":"Vicari AP, Schoepfer AM, Meresse B, Goffin L, L\u00e9ger O, Josserand S, et al. Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis. MAbs. 2017;9:927\u201344.","journal-title":"MAbs"},{"key":"634_CR62","doi-asserted-by":"publisher","first-page":"S-129","DOI":"10.1016\/S0016-5085(18)30859-X","volume":"154","author":"C Cellier","year":"2018","unstructured":"Cellier C, et al. 616 - AMG 714 (Anti-IL-15 MAB) Halts the progression of aberrant intraepithelial lymphocytes in refractory celiac disease type II (RCD-II): a phase 2A, randomized, double-blind, placebo-controlled study evaluating AMG 714 in adult patients with RCD-II\/Pre. Gastroenterology. 2018;154:S-129\u201330.","journal-title":"Gastroenterology"},{"key":"634_CR63","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s11899-018-0480-8","volume":"13","author":"P Ghione","year":"2018","unstructured":"Ghione P, Moskowitz AJ, De Paola NEK, Horwitz SM, Ruella M. Novel immunotherapies for T cell lymphoma and leukemia. Curr Hematol Malig Rep. 2018;13:494\u2013506.","journal-title":"Curr Hematol Malig Rep"},{"key":"634_CR64","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1182\/blood-2017-08-802470","volume":"131","author":"SM Horwitz","year":"2018","unstructured":"Horwitz SM, Koch R, Porcu P, Oki Y, Moskowitz A, Perez M, et al. Activity of the PI3K-\u03b4,\u03b3 inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. Blood. 2018;131:888\u201398.","journal-title":"Blood"},{"key":"634_CR65","doi-asserted-by":"crossref","unstructured":"Broccoli A, Zinzani PL. Phosphatidyl-inositol 3-kinase inhibitors in the treatment of T-cell lymphomas. Ann Lymphoma. 2018;2(1).","DOI":"10.21037\/aol.2017.12.01"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-021-00634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-021-00634-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-021-00634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T09:52:12Z","timestamp":1675331532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-021-00634-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1007\/s11899-021-00634-4","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"12 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}